In agreement with this postulate, in an unbiased CRISPR screen in DLBCL cell lines, IRF8 was identified as an “essential oncogene” (37), and we found the IRF8 deletion abolishes B cell lymphoma growth in vivo. The gene discussed is IRF8; the disease is B-cell non-Hodgkin lymphoma.